يعرض 1 - 20 نتائج من 59 نتيجة بحث عن '"Neimark E"', وقت الاستعلام: 0.53s تنقيح النتائج
  1. 1
    Academic Journal
    Epidemiology of Pars Plana Vitrectomy in the Elderly: A Retrospective 10-Year Survey of 592 Cases

    المؤلفون: Elyashiv S, Fogel Levin M, Zloto O, Neimark E, Najjar R, Moisseiev J, Vidne-Hay O

    المصدر: Clinical Interventions in Aging, Vol Volume 16, Pp 1007-1012 (2021)

    مصطلحات موضوعية: aged, epidemiology, pars plana vitrectomy, Geriatrics, RC952-954.6

    وصف الملف: electronic resource

    Relation: https://www.dovepress.com/epidemiology-of-pars-plana-vitrectomy-in-the-elderly-a-retrospective-1-peer-reviewed-fulltext-article-CIA; https://doaj.org/toc/1178-1998

    URL الوصول: https://doaj.org/article/7f38995b2e0141c697b8cee5f56bc130

    View record in DOAJ Full Text Finder

    أضف إلى المفضلة
  2. 2
    Academic Journal
    P661 Clinical response over 24 weeks for initial and delayed responders to induction therapy with risankizumab in Crohn’s disease: data from the ADVANCE and MOTIVATE studies

    المؤلفون: Panaccione, R, Dotan, I, Ferrante, M, Danese, S, Bossuyt, P, Kligys, K, Neimark, E, Zambrano, J, Liao, X, D’Haens, G

    المصدر: Journal of Crohn's and Colitis ; volume 17, issue Supplement_1, page i790-i791 ; ISSN 1873-9946 1876-4479

    الاتاحة: https://doi.org/10.1093/ecco-jcc/jjac190.0791
    https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i790/51511603/jjac190.0791.pdf

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Academic Journal
    P548 Efficacy outcomes of placebo maintenance treatment in patients with moderate to severe Crohn’s disease who responded to placebo induction therapy: Post-hoc analysis of the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Risankizumab Studies

    المؤلفون: Atreya, R, Irving, P, Fujiya, M, Colombel, J F, Danese, S, Peyrin-Biroulet, L, Bessissow, T, Panaccione, R, D’Haens, G, van Haaren, S, Neimark, E, Zambrano, J, Zhang, Y, Kligys, K, Ferrante, M

    المصدر: Journal of Crohn's and Colitis ; volume 17, issue Supplement_1, page i675-i677 ; ISSN 1873-9946 1876-4479

    الاتاحة: https://doi.org/10.1093/ecco-jcc/jjac190.0678
    https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i675/51511662/jjac190.0678.pdf

    View record in BASE

    أضف إلى المفضلة
  4. 4
    Academic Journal
    DOP84 Risankizumab maintenance therapy results in sustained improvements in endoscopic outcomes in patients with moderate to severe Crohn’s Disease: Post-hoc analysis from the phase 3 study FORTIFY

    المؤلفون: Irving, P M, Abreu, M, Axler, J, Gao, X, Torres, J, Neimark, E, Song, A, Wallace, K, Kligys, K, Berg, S, Liao, X, Panaccione, R

    المصدر: Journal of Crohn's and Colitis ; volume 16, issue Supplement_1, page i127-i128 ; ISSN 1873-9946 1876-4479

    الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjab232.123
    https://academic.oup.com/ecco-jcc/article-pdf/16/Supplement_1/i127/42250657/jjab232.123.pdf

    View record in BASE

    أضف إلى المفضلة
  5. 5
    Academic Journal
    OP25 Patients with moderate to severe Crohn’s Disease with and without prior biologic failure demonstrate improved endoscopic outcomes with risankizumab: Results from phase 3 induction and maintenance trials

    المؤلفون: Ferrante, M, Cao, Q, Fujii, T, Rausch, A, Neimark, E, Song, A, Wallace, K, Kligys, K, Zhou, Q, Kalabic, J, Feagan, B G

    المصدر: Journal of Crohn's and Colitis ; volume 16, issue Supplement_1, page i027-i028 ; ISSN 1873-9946 1876-4479

    مصطلحات موضوعية: Gastroenterology, General Medicine

    الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjab232.024
    https://academic.oup.com/ecco-jcc/article-pdf/16/Supplement_1/i027/42250310/jjab232.024.pdf

    View record in BASE

    أضف إلى المفضلة
  6. 6
    Academic Journal
    A37 EFFICACY AND SAFETY OF RISANKIZUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH CROHN’S DISEASE: 52 WEEK RESULTS FROM THE PHASE 3 FORTIFY STUDY

    المؤلفون: Panaccione, R, Ferrante, M, Feagan, B G, Sandborn, W, Panes, J, Peyrin-Biroulet, L, Colombel, J, Schreiber, S, Dubinsky, M, Baert, F, Hisamatsu, T, Neimark, E, Huang, B, Liao, X, Song, A, Berg, S, Duan, W, Pang, Y, Pivorunas, V, Kligys, K, Wallace, K, D’Haens, G

    المصدر: Journal of the Canadian Association of Gastroenterology ; volume 5, issue Supplement_1, page 43-45 ; ISSN 2515-2084 2515-2092

    الاتاحة: http://dx.doi.org/10.1093/jcag/gwab049.036
    https://academic.oup.com/jcag/article-pdf/5/Supplement_1/43/42564857/gwab049.036.pdf

    View record in BASE

    أضف إلى المفضلة
  7. 7
    Academic Journal
    DOP83 Normalisation of biomarkers and improvement in clinical outcomes in patients with Crohn’s Disease treated with risankizumab in the phase 3 ADVANCE, MOTIVATE, and FORTIFY studies

    المؤلفون: Atreya, R, Feagan, B, Shchukina, O, Jairath, V, Rieder, F, Hisamatsu, T, Siegmund, B, Rizzo, J, Kligys, K, Neimark, E, Song, A, Zambrano, J, Mallick, M, Cheng, E, Armuzzi, A

    المصدر: Journal of Crohn's and Colitis ; volume 16, issue Supplement_1, page i126-i127 ; ISSN 1873-9946 1876-4479

    مصطلحات موضوعية: Gastroenterology, General Medicine

    الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjab232.122
    https://academic.oup.com/ecco-jcc/article-pdf/16/Supplement_1/i126/42250439/jjab232.122.pdf

    View record in BASE

    أضف إلى المفضلة
  8. 8
    Academic Journal
    DOP82 Achievement of steroid-free remission in patients with moderately to severely active Crohn’s Disease during treatment with risankizumab

    المؤلفون: Schreiber, S W, Cross, R, Panaccione, R, D’Haens, G, Bossuyt, P, Colombel, J F, Louis, E, Dubinsky, M, Kligys, K, Neimark, E, Song, A, Zambrano, J, Cheng, E, Ferrante, M

    المصدر: Journal of Crohn's and Colitis ; volume 16, issue Supplement_1, page i125-i126 ; ISSN 1873-9946 1876-4479

    مصطلحات موضوعية: Gastroenterology, General Medicine

    الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjab232.121
    https://academic.oup.com/ecco-jcc/article-pdf/16/Supplement_1/i125/42250443/jjab232.121.pdf

    View record in BASE

    أضف إلى المفضلة
  9. 9
    Academic Journal
    P544 Patients with moderate to severe Crohn’s disease with and without prior biologic failure demonstrated improved clinical outcomes with risankizumab: Results from phase 3 induction and maintenance trials

    المؤلفون: D’Haens, G, Beaton, M, Bossuyt, P, Dotan, I, Sands, B, Sugimoto, K, Neimark, E, Song, A, Wallace, K, Zhou, Q, Kligys, K, Ferrante, M

    المصدر: Journal of Crohn's and Colitis ; volume 16, issue Supplement_1, page i491-i491 ; ISSN 1873-9946 1876-4479

    مصطلحات موضوعية: Gastroenterology, General Medicine

    الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjab232.671
    https://academic.oup.com/ecco-jcc/article-pdf/16/Supplement_1/i491/42253201/jjab232.671.pdf

    View record in BASE

    أضف إلى المفضلة
  10. 10
    Academic Journal
    DOP85 Efficacy of risankizumab rescue therapy in patients with moderately to severely active Crohn’s Disease and inadequate response to risankizumab maintenance therapy

    المؤلفون: Baert, F J, Atreya, R, Kakuta, Y, Long, M, Roblin, X, Neimark, E, Song, A, Wallace, K, Kingys, K, Mallick, M, Liao, X, Lim, A

    المصدر: Journal of Crohn's and Colitis ; volume 16, issue Supplement_1, page i128-i128 ; ISSN 1873-9946 1876-4479

    مصطلحات موضوعية: Gastroenterology, General Medicine

    الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjab232.124
    https://academic.oup.com/ecco-jcc/article-pdf/16/Supplement_1/i128/42250654/jjab232.124.pdf

    View record in BASE

    أضف إلى المفضلة
  11. 11
    Academic Journal
    OP06 Risankizumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomised Phase 3 COMMAND Study

    المؤلفون: Louis, E, Panaccione, R, Parkes, G, Peyrin-Biroulet, L, Ferrante, M, Hisamatsu, T, Siegmund, B, Kalabic, J, Levine, P, Neimark, E, Wallace, K, Chen, S, Cheng, L, Duan, W R, Armuzzi, A, Biederman, L, Loftus, E, Melmed, G, Schreiber, S

    المصدر: Journal of Crohn's and Colitis ; volume 18, issue Supplement_1, page i10-i12 ; ISSN 1873-9946 1876-4479

    الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjad212.0006
    https://academic.oup.com/ecco-jcc/article-pdf/18/Supplement_1/i10/56347663/jjad212.0006.pdf

    View record in BASE

    أضف إلى المفضلة
  12. 12
    Academic Journal
    DOP10 Risankizumab Versus Ustekinumab for the Achievement of Endoscopic Outcomes in Patients With Moderate-to-Severe Crohn’s Disease: Results From the Phase 3b SEQUENCE Trial

    المؤلفون: Peyrin-Biroulet, L, Bossuyt, P, Regueiro, M, Schreiber, S, Gecse, K, Irving, P, D’Haens, G, Cao, Q, Neimark, E, Huang, X, Anschutz, T, Kligys, K, O’Brien, D, Panaccione, R

    المصدر: Journal of Crohn's and Colitis ; volume 18, issue Supplement_1, page i90-i91 ; ISSN 1873-9946 1876-4479

    الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjad212.0050
    https://academic.oup.com/ecco-jcc/article-pdf/18/Supplement_1/i90/56347446/jjad212.0050.pdf

    View record in BASE

    أضف إلى المفضلة
  13. 13
    Academic Journal
    DOP53 Long-term Efficacy and Safety of Risankizumab in Patients With Moderate to Severe Crohn's Disease up to 3 Years of Treatment: Results From the FORTIFY Open-Label Long-term Extension

    المؤلفون: Ferrante, M, Panaccione, R, Colombel, J F, Dubinsky, M, Hisamatsu, T, Lindsay, J O, Song, A, Neimark, E, Zhang, Y, Kligys, K, Crowley, J, Duan, W R, D’Haens, G

    المصدر: Journal of Crohn's and Colitis ; volume 18, issue Supplement_1, page i168-i170 ; ISSN 1873-9946 1876-4479

    الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjad212.0093
    https://academic.oup.com/ecco-jcc/article-pdf/18/Supplement_1/i168/56348438/jjad212.0093.pdf

    View record in BASE

    أضف إلى المفضلة
  14. 14
    Academic Journal
    OP36 Risankizumab Versus Ustekinumab for the Achievement of Clinical Outcomes and Symptom Improvement in Patients With Moderate To Severe Crohn’s Disease: Results From the Phase 3b SEQUENCE Trial

    المؤلفون: Dubinsky, M C, D’Haens, G, Atreya, R, Abraham, B, Armuzzi, A, Arguelles-Arias, F, Lindsay, J O, Patel, K, Neimark, E, Huang, X, Anschutz, T, van Haaren, S, O’Brien, D, Ferrante, M

    المصدر: Journal of Crohn's and Colitis ; volume 18, issue Supplement_1, page i65-i66 ; ISSN 1873-9946 1876-4479

    مصطلحات موضوعية: Gastroenterology, General Medicine

    الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjad212.0036
    https://academic.oup.com/ecco-jcc/article-pdf/18/Supplement_1/i65/56347963/jjad212.0036.pdf

    View record in BASE

    أضف إلى المفضلة
  15. 15
    Academic Journal
    DOP64 Steroid-sparing effect of risankizumab vs ustekinumab in patients with moderately to severely active Crohn’s Disease: Post hoc results from the phase 3b SEQUENCE trial

    المؤلفون: Raine, T, Danese, S, Schreiber, S, Gao, X, Hanauer, S, Torres, J, Kligys, K, Huang, X, Neimark, E, Anschutz, T, Crowley, J, Cross, R K

    المصدر: Journal of Crohn's and Colitis ; volume 18, issue Supplement_1, page i190-i190 ; ISSN 1873-9946 1876-4479

    مصطلحات موضوعية: Gastroenterology, General Medicine

    الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjad212.0104
    https://academic.oup.com/ecco-jcc/article-pdf/18/Supplement_1/i190/56347913/jjad212.0104.pdf

    View record in BASE

    أضف إلى المفضلة
  16. 16
    Academic Journal
    P593 Efficacy of Risankizumab in Patients With Moderately to Severely Active Ulcerative Colitis by Prior Advanced Therapy Failure and Mechanism of Action: Post Hoc Analysis of the INSPIRE and COMMAND Phase 3 Studies

    المؤلفون: Panaccione, R, Louis, E, Colombel, J F, D'Haens, G, Peyrin-Biroulet, L, Dubinsky, M, Takeuchi, K, Kalabic, J, Levine, P, Neimark, E, Chen, S, Cheng, L, Duan, W R, Vladea, R, Hecht, P M, Sanchez Gonzalez, Y, Schreiber, S, Ferrante, M

    المصدر: Journal of Crohn's and Colitis ; volume 18, issue Supplement_1, page i1153-i1155 ; ISSN 1873-9946 1876-4479

    مصطلحات موضوعية: Gastroenterology, General Medicine

    الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjad212.0723
    https://academic.oup.com/ecco-jcc/article-pdf/18/Supplement_1/i1153/56348859/jjad212.0723.pdf

    View record in BASE

    أضف إلى المفضلة
  17. 17
    Academic Journal
    DOP18 Efficacy of risankizumab versus ustekinumab by baseline Crohn’s Disease location: post-hoc analysis of the SEQUENCE head-to-head trial

    المؤلفون: Peyrin-Biroulet, L, Colombel, J F, D’Haens, G, Dubinsky, M, Cao, Q, Kligys, K, Garrison, A, Huang, X, Neimark, E, Anschutz, T, Crowley, J, Panaccione, R

    المصدر: Journal of Crohn's and Colitis ; volume 18, issue Supplement_1, page i104-i105 ; ISSN 1873-9946 1876-4479

    مصطلحات موضوعية: Gastroenterology, General Medicine

    الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjad212.0058
    https://academic.oup.com/ecco-jcc/article-pdf/18/Supplement_1/i104/56347820/jjad212.0058.pdf

    View record in BASE

    أضف إلى المفضلة
  18. 18
    Academic Journal
    OP26 Risankizumab induces early clinical remission and response in patients with Moderate-to-Severe Crohn’s Disease: Results from the phase 3 ADVANCE and MOTIVATE studies

    المؤلفون: Schreiber, S W, Ferrante, M, Panaccione, R, Colombel, J F, Hisamatsu, T, Lim, A, Lindsay, J O, Rubin, D T, Sandborn, W J, Neimark, E, Song, A P, Liao, X, Feng, T, Berg, S, Wallace, K, D’Haens, G R

    المصدر: Journal of Crohn's and Colitis ; volume 15, issue Supplement_1, page S026-S027 ; ISSN 1873-9946 1876-4479

    الاتاحة: https://doi.org/10.1093/ecco-jcc/jjab075.025
    http://academic.oup.com/ecco-jcc/article-pdf/15/Supplement_1/S026/38312936/jjab075.025.pdf

    View record in BASE

    أضف إلى المفضلة
  19. 19
    Academic Journal
    OP36 Risankizumab therapy induces improvements in endoscopic endpoints in patients with Moderate-to-Severe Crohn’s Disease: Results from the phase 3 ADVANCE and MOTIVATE studies

    المؤلفون: Bossuyt, P, Ferrante, M, Baert, F, Danese, S, Feagan, B G, Loftus Jr, E V, Panés, J, Peyrin-Biroulet, L, Ran, Z, Armuzzi, A, D’Haens, G R, Song, A, Neimark, E, Liao, X, Zhou, Q, Berg, S, Wallace, K, Panaccione, R

    المصدر: Journal of Crohn's and Colitis ; volume 15, issue Supplement_1, page S033-S034 ; ISSN 1873-9946 1876-4479

    الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjab075.035
    http://academic.oup.com/ecco-jcc/article-pdf/15/Supplement_1/S033/38312329/jjab075.035.pdf

    View record in BASE

    أضف إلى المفضلة
  20. 20
    Conference
    PTH-077 De-escalating therapy in patients with crohn’s disease receiving adalimumab: subgroup analysis of the calm study

    المؤلفون: Bossuyt, P, D’Haens, G, Panaccione, R, Sandborn, W, Reinisch, W, Travis, S, Schreiber, S, Armuzzi, A, Danese, S, Berg, S, Petersson, J, Maa, J-F, Neimark, E, Colombel, J-F

    المصدر: Posters ; page A70.2-A71

    الاتاحة: http://dx.doi.org/10.1136/gutjnl-2019-bsgabstracts.136
    https://syndication.highwire.org/content/doi/10.1136/gutjnl-2019-BSGAbstracts.136

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء